Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGRGlobal Implantable DefibrillatorsMarket, By Product Type (Single Chambered Implantable Defibrillators, Dual Chambered Implantable Defibrillators, Biventricular Implantable Defibrillators), Procedure Type (Trans-Venous Implantable Defibrillators, Subcutaneous Implantable Defibrillators), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Industry Trends and Forecast to 2029.
Implantable Defibrillators Market Analysis and Size
To track the patient's heart rate, implantable defibrillators—tiny, battery-operated devices—are positioned beneath the patient's chest or abdomen. When palpitations increase, the device notices this and restarts the heartbeat normally. In individuals who have chronic ventricular tachycardia or atrial fibrillation, these devices are essential for preventing sudden cardiac arrest. ICDs use electrodes to continuously monitor the heart rhythm and, if an abnormal rhythm is discovered, to give treatments.
Data Bridge Market Research analyses that the implantable defibrillators market which was USD 2.22 billion in 2021, would rocket up to USD 3.89 billion by 2029, and is expected to undergo a CAGR of 7.25% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Implantable Defibrillators Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product Type (Single Chambered Implantable Defibrillators, Dual Chambered Implantable Defibrillators, Biventricular Implantable Defibrillators), Procedure Type (Trans-Venous Implantable Defibrillators, Subcutaneous Implantable Defibrillators), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Abbott (U.S.), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), Fukuda Denshi (Japan), Imricor (U.S.), Koninklijke Philips N.V. (Netherlands), LivaNova Plc (U.K.), Medtronic (Ireland), Nihon Kohden Corporation (Japan), MicroPort Scientific Corporation (China), Mayo Clinic (U.S.), MRI Interventions, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Sorin Group (Italy) |
|
Market Opportunities |
|
Market Definition
A piece of equipment or a device known as an implanted cardioverter defibrillator (ICD) is used to perform cardioversion, correct pacing, and heart defibrillation inside of a human body. The drug is primarily used to treat cardiac arrhythmias, pulseless ventricular tachycardia, and ventricular fibrillation, all of which can result in sudden cardiac arrest.
Implantable Defibrillators Market Dynamics
Drivers
- Growing geriatric population
The growing prevalence of cardiovascular diseases, growing geriatric population worldwide, changing lifestyle habits, rising smoking rate, rising prevalence of seizures and strokes, and growing technological advancements in the medical device industry are the contributing factors to the global implantable defibrillator market. These factors have increased demand for implantable defibrillators encompassing the globe.
- Rise in cardiovascular diseases
During the forecast period of 2022 to 2029, the market for implantable defibrillators will be driven by the rising prevalence of cardiovascular disorders and the development of small-sized heart monitoring devices.
- Increase in atrial fibrillation cases
The development of magnetic resonance imaging (MRI)-safe implanted cardioverter defibrillators (ICDs) and the introduction of quadrupoles lead devices have all contributed to the expansion of the market for implantable defibrillators.
Opportunities
The demand for implantable defibrillator devices is also fuelled by an increase in atrial fibrillation cases and the significant risk of a sudden cardiac arrest (SCA).
Restraints/Challenges
On the other hand, the concerns associated with the application of implantable and automatic visible defibrillators, and regular merchandise reassemble will obstruct the market's growth rate.
This implantable defibrillators market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the implantable defibrillators market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Implantable Defibrillators Market
The COVID-19 epidemic has significantly impacted the market for implantable defibrillators. The COVID-19 epidemic had a favourable impact on market expansion. The healthcare industry is under severe strain as a result of an increase in coronavirus incidence around the world. Heart implants are becoming more popular during the pandemic because to an increase in heart patients and cardiovascular problems, as well as the fact that these people are more likely to contract COVID-19. The cardiovascular system may be impacted by COVID-19, leading to myocardial damage, arrhythmias, intravascular thrombosis, and sudden cardiac death.
Global Implantable Defibrillators Market Scope
The implantable defibrillators market is segmented on the basis of product type, procedure type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Single Chambered Implantable Defibrillators
- Dual Chambered Implantable Defibrillators
- Biventricular Implantable Defibrillators
Procedure Type
- Trans-Venous Implantable Defibrillators
- Subcutaneous Implantable Defibrillators
End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Implantable Defibrillators Market Regional Analysis/Insights
The implantable defibrillators market is analysed and market size insights and trends are provided by country, product type, procedure type and end user as referenced above.
The countries covered in the implantable defibrillators market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the implantable defibrillators market due to the growing number of geriatric population along with adoption of innovative medical technology.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Implantable Defibrillators Market Share Analysis
The implantable defibrillators market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to implantable defibrillators market.
Some of the major players operating in the implantable defibrillators market are:
- Abbott (U.S.)
- Biotronik SE & Co. KG (Germany)
- Boston Scientific Corporation (U.S.)
- Fukuda Denshi (Japan)
- Imricor (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- LivaNova Plc (U.K.)
- Medtronic (Ireland)
- Nihon Kohden Corporation (Japan)
- MicroPort Scientific Corporation (China)
- Mayo Clinic (U.S.)
- MRI Interventions, Inc. (U.S.)
- St. Jude Medical, Inc. (U.S.)
- Sorin Group (Italy)
SKU-
